autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011602
A cell-based vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from heat-treated allogeneic melanoma tumor cells. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T-cell and antibody responses to melanoma cells bearing shared melanoma antigens such as MelanA/MART-1, gp100, MAGE3, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-011602 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Allogeneic Melanoma Cell-Loaded Dendritic Cell Vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011602",
"term": "autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine",
"field": "Oncology and biomedicine",
"definition": "A cell-based vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from heat-treated allogeneic melanoma tumor cells. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T-cell and antibody responses to melanoma cells bearing shared melanoma antigens such as MelanA/MART-1, gp100, MAGE3, resulting in tumor cell lysis.",
"synonyms": [
"Allogeneic Melanoma Cell-Loaded Dendritic Cell Vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine/"
}
Record 2,936 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.